Unexpected finding of a rare pathogenic germline BRCA1 variant in an intrahepatic cholangiocarcinoma using the Oncomine Focus DNA assay: clinical and diagnostic implications
出版年份 2023 全文链接
标题
Unexpected finding of a rare pathogenic germline BRCA1 variant in an intrahepatic cholangiocarcinoma using the Oncomine Focus DNA assay: clinical and diagnostic implications
作者
关键词
-
出版物
MOLECULAR BIOLOGY REPORTS
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2023-06-21
DOI
10.1007/s11033-023-08588-x
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Cholangiocarcinoma — novel biological insights and therapeutic strategies
- (2023) Sumera I. Ilyas et al. Nature Reviews Clinical Oncology
- FDA Approval Summary: Pemigatinib for Previously Treated, Unresectable Locally Advanced or Metastatic Cholangiocarcinoma with FGFR2 Fusion or Other Rearrangement
- (2022) Timil H. Patel et al. CLINICAL CANCER RESEARCH
- Integrating a Comprehensive Cancer Genome Profiling into Clinical Practice: A Blueprint in an Italian Referral Center
- (2022) Camilla Nero et al. Journal of Personalized Medicine
- Futibatinib: First Approval
- (2022) Yahiya Y. Syed DRUGS
- Cholangiocarcinoma: what are the options in all comers and how has the advent of molecular profiling opened the way to personalised medicine ?
- (2022) Gael S. Roth et al. EUROPEAN JOURNAL OF CANCER
- A Computational Framework for Comprehensive Genomic Profiling in Solid Cancers: The Analytical Performance of a High-Throughput Assay for Small and Copy Number Variants
- (2022) Luciano Giacò et al. Cancers
- Targeted Therapy for Advanced or Metastatic Cholangiocarcinoma: Focus on the Clinical Potential of Infigratinib
- (2021) James Yu et al. OncoTargets and Therapy
- BRCA testing in a genomic diagnostics referral center during the COVID-19 pandemic
- (2020) Angelo Minucci et al. MOLECULAR BIOLOGY REPORTS
- Molecular profile of BRCA-mutated biliary tract cancers
- (2020) Gilbert Spizzo et al. ESMO Open
- Validation of the Oncomine™ focus panel for next-generation sequencing of clinical tumour samples
- (2018) Hannah L. Williams et al. VIRCHOWS ARCHIV
- Treatment with olaparib monotherapy for BRCA2-mutated refractory intrahepatic cholangiocarcinoma: a case report
- (2018) Yuan Cheng et al. OncoTargets and Therapy
- Overall Survival and Clinical Characteristics of BRCA‐Associated Cholangiocarcinoma: A Multicenter Retrospective Study
- (2017) Talia Golan et al. ONCOLOGIST
- Whole-Genome and Epigenomic Landscapes of Etiologically Distinct Subtypes of Cholangiocarcinoma
- (2017) Apinya Jusakul et al. Cancer Discovery
- Clinical impact on ovarian cancer patients of massive parallel sequencing forBRCAmutation detection: the experience at Gemelli hospital and a literature review
- (2015) Angelo Minucci et al. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
- American Society of Clinical Oncology Policy Statement Update: Genetic and Genomic Testing for Cancer Susceptibility
- (2015) Mark E. Robson et al. JOURNAL OF CLINICAL ONCOLOGY
- Olaparib Monotherapy in Patients With Advanced Cancer and a GermlineBRCA1/2Mutation
- (2015) Bella Kaufman et al. JOURNAL OF CLINICAL ONCOLOGY
- Genomic spectra of biliary tract cancer
- (2015) Hiromi Nakamura et al. NATURE GENETICS
- Mutation Profiling in Cholangiocarcinoma: Prognostic and Therapeutic Implications
- (2014) Chaitanya R. Churi et al. PLoS One
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started